Eli Lilly gets a new price target after a big rally. Should I buy more shares?

Health, Fitness & Food

Here’s our Club Mailbag email investingclubmailbag@cnbc.com — so you send your questions directly to Jim Cramer and his team of analysts. We can’t offer personal investing advice. We will only consider more general questions about the investment process or stocks in the portfolio or related industries.

This week’s question: I’m learning so much from the Club about when to buy and sell. One piece of the puzzle that still confuses me is the price target. Using Eli Lilly as an example: Jim posted a new 12-month price target of $600 and the stock is around $528. A purchase now would result in a 14% increase. Of course, getting shares at a lower cost would be more profitable, but I would also not want to give up a 14% potential gain. How does an investor take the price target into consideration? — Thank you, Kathy

Products You May Like

Articles You May Like

Smoked Salmon Cucumber Bites
CVS, UnitedHealth, Cigna sue to block FTC case over insulin prices
My First Contortion Class Was Humbling — Here’s What It Taught Me
Best Teas For Anxiety, According to an Expert
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy

Leave a Reply

Your email address will not be published. Required fields are marked *